statistiche ricercatore

Continente	#
NA - Nord America	1.196
EU - Europa	711
AS - Asia	418
SA - Sud America	47
AF - Africa	8
OC - Oceania	8
Continente sconosciuto - Info sul continente non disponibili	6
Totale	2.394

Nazione	#
US - Stati Uniti d'America	1.174
RU - Federazione Russa	221
SG - Singapore	146
PL - Polonia	137
CN - Cina	93
IT - Italia	90
HK - Hong Kong	60
SE - Svezia	59
IE - Irlanda	57
VN - Vietnam	42
UA - Ucraina	40
DE - Germania	37
BR - Brasile	33
KR - Corea	29
GB - Regno Unito	18
FI - Finlandia	16
FR - Francia	16
CA - Canada	11
AU - Australia	8
IN - India	7
BD - Bangladesh	6
MX - Messico	6
BE - Belgio	5
JO - Giordania	5
TR - Turchia	5
EC - Ecuador	4
PH - Filippine	4
AR - Argentina	3
CH - Svizzera	3
CI - Costa d'Avorio	3
ID - Indonesia	3
IQ - Iraq	3
VE - Venezuela	3
DK - Danimarca	2
ES - Italia	2
NL - Olanda	2
PK - Pakistan	2
SA - Arabia Saudita	2
TH - Thailandia	2
AE - Emirati Arabi Uniti	1
AO - Angola	1
AT - Austria	1
AW - Aruba	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BO - Bolivia	1
BZ - Belize	1
CR - Costa Rica	1
DO - Repubblica Dominicana	1
GA - Gabon	1
GY - Guiana	1
IL - Israele	1
JP - Giappone	1
KE - Kenya	1
KH - Cambogia	1
MY - Malesia	1
NO - Norvegia	1
OM - Oman	1
PE - Perù	1
PR - Porto Rico	1
PS - Palestinian Territory	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
SC - Seychelles	1
SK - Slovacchia (Repubblica Slovacca)	1
UZ - Uzbekistan	1
ZA - Sudafrica	1
Totale	2.388

Nome	#
Evidence for oxidative stress in plasma of patients with Marfan syndrome	352
FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations.	235
A single heterozygous nucleotide substitution displays two different altered mechanisms in the FBN1 gene of five Italian Marfan patients	215
RISK FACTORS FOR CARDIOVASCULAR DISEASE IN RENAL TRANSPLANT RECIPIENTS: NEW INSIGHTS	206
Fibroblast autofluorescence in connective tissue disorders: a future tool for clinical and differential diagnosis?	202
Is ectopia lentis in some cases a mild phenotypic expression of Marfan syndrome? Need for a long-term follow-up.	187
Hyperhomocysteinemia in renal transplant patients as independent cause of endothelial damage and cardiovascular disease.	186
Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: Role of dural ectasia for the diagnosis.	175
Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.	174
FIBRILLIN-1 (FBN1) GENE FRAMESHIFT MUTATIONS IN MARFAN PATIENTS: GENOTYPE-PHENOTYPE CORRELATION	165
Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion	160
Marfan's syndrome. Clinical and molecular characterization of 51 italian patients	137
Totale	2.394

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	65	0	0	0	3	4	5	1	5	2	6	12	27
2022/2023	299	21	58	12	32	32	45	36	26	27	1	5	4
2023/2024	78	2	9	11	7	3	15	6	19	2	2	0	2
2024/2025	623	19	60	37	100	182	95	5	47	31	8	20	19
2025/2026	567	66	84	44	27	80	27	62	28	38	39	12	60
2026/2027	125	18	25	61	21	0	0	0	0	0	0	0	0
Totale													2.394